Omslagsbild från Amazon
Bild från Amazon.com

The economic dynamics of modern biotechnology / edited by Maureen McKelvey, Annike Rickne, Jens Laage-Hellman.

Medverkande: Materialtyp: TextTextSpråk: Engelska Utgivningsuppgift: Cheltenham : Edward Elgar, cop. 2004Beskrivning: xi, 418 s. illISBN:
  • 1843765195
  • 1845427904
Ämnen: DDK-klassifikation:
  • 338.4/76606/094 22
Innehåll:
Part I: Introduction -- 1. Introduction -- 2. Conceptualizing and measuring modern biotechnology -- Part II: Setting the scene -- 3. Stylized facts about innovation processes in modern biotechnology -- 4. The post-genome era: rupture in the organization of the life science industry? -- 5. An overview of biotechnology innovation in Europe: firms, demand, government policy and research -- Part III: Challenging the existing -- 6. Risk management and the commercialization of human genetic testing in the UK -- 7. Networks and the technology systems in science-driven fields: the case of European food biotechnology -- 8. Future imperfect: the response of the insurance industry to the emergence of predictive genetic testing -- 9. Emergent bioinformatics and newly distributed innovation processes -- Part IV: Forming the new -- 10. The dynamics of regional specialization in modern biotechnology: comparing two regions in Sweden and two regions in Australia, 1977-2001 -- 11. On the spatial dimension of firm information -- 12. Examining the marketplace for ideas: how local are Europe's biotechnology clusters? -- 13. Creation and growth of high-tech SMEs: the role of the local environment -- Part V: Conclusions -- 14. Reflections and ways forward
Bestånd
Exemplartyp Aktuellt bibliotek Hyllsignatur Status Streckkod
Bok Högskolan Väst Entréplan / Entrance floor 338.4766 Economic Tillgänglig 6005320029325
Antal reservationer: 0

Part I: Introduction -- 1. Introduction -- 2. Conceptualizing and measuring modern biotechnology -- Part II: Setting the scene -- 3. Stylized facts about innovation processes in modern biotechnology -- 4. The post-genome era: rupture in the organization of the life science industry? -- 5. An overview of biotechnology innovation in Europe: firms, demand, government policy and research -- Part III: Challenging the existing -- 6. Risk management and the commercialization of human genetic testing in the UK -- 7. Networks and the technology systems in science-driven fields: the case of European food biotechnology -- 8. Future imperfect: the response of the insurance industry to the emergence of predictive genetic testing -- 9. Emergent bioinformatics and newly distributed innovation processes -- Part IV: Forming the new -- 10. The dynamics of regional specialization in modern biotechnology: comparing two regions in Sweden and two regions in Australia, 1977-2001 -- 11. On the spatial dimension of firm information -- 12. Examining the marketplace for ideas: how local are Europe's biotechnology clusters? -- 13. Creation and growth of high-tech SMEs: the role of the local environment -- Part V: Conclusions -- 14. Reflections and ways forward